Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: Implications for autoimmunity in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 75, Issue 6, 2016, Pages 1255-1261

  Montgomery, Anna B ^a   Kopec, Jolanta ^b   Shrestha, Leela ^b   Thezenas, Marie Laetitia ^b   Burgess Brown, Nicola A ^b   Fischer, Roman ^b   Yue, Wyatt W ^b   Venables, Patrick J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; ARGININE; ARGININE 152; ARGININE 154; ASPARAGINE; ASPARAGINE 297; ASPARTIC ACID; ASPARTIC ACID 130; ASPARTIC ACID 238; BACTERIAL PROTEIN; CYSTEIN 351; CYSTEINE; FIBRINOGEN; HISTIDINE; HISTIDINE 236; PROTEIN ARGININE DEIMINASE; RGPB PROTEIN; UNCLASSIFIED DRUG; CITRULLINE; HYDROLASE; PROTEIN-ARGININE DEIMINASE;

AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNITY; BACTERIUM IDENTIFICATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; MASS SPECTROMETRY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESIDUE ANALYSIS; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; CATALYSIS; CHEMISTRY; CRYSTALLIZATION; ENZYMOLOGY; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; MOLECULAR MODEL; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CATALYSIS; CITRULLINE; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROLASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PORPHYROMONAS GINGIVALIS; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 84938099309     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207656     Document Type: Article

References (40)

1. de Smit MJ, Brouwer E, Westra J, et al. [Effect of periodontal treatment on rheumatoid arthritis and vice versa]. Ned Tijdschr Tandheelkd 2012;119:191-7.
2. Rosamma J, Sreeraj R, Sameera NSG, et al. Association between chronic periodontitis and rheumatoid arthritis: A hospital-based case-control study. Rheumatol Int 2013;33:103-9
3. Mikuls TR, Payne JB, Yu F, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 2014;66:1090-100.
4. Gonzalez SM, Payne JB, Yu F, et al. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in rheumatoid arthritis patients. J Periodontol 2014;86:1-16
5. de Pablo P, Dietrich T, Chapple IL, et al. The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Ann Rheum Dis 2014;73:580-6.
6. Kinloch A, Lundberg K, Wait R, et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum 2008;58:2287-95
7. Nesse W, Westra J, van der Wal JE, et al. The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. J Clin Periodontol 2012;39:599-607.
8. Arita K, Hashimoto H, Shimizu T, et al. Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol 2004;11:777-83
9. Slade DJ, Fang P, Dreyton CJ, et al. Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design. ACS Chem Biol 2015;10:1043-53.
10. Lugli EB, Correia R, Fischer R, et al. Expression of citrulline and homocitrulline residues in the lungs of non-smokers and smokers: Implications for autoimmunity in rheumatoid arthritis. Arthritis Res Ther 2015;17:9
11. Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol 2012;10:717-25.
12. Quirke AM, Lugli EB, Wegner N, et al. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: A potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis 2014;73:263-9
13. Mikuls TR, Thiele GM, Deane KD, et al. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012;64:3522-30.
14. Shirai H, Blundell TL, Mizuguchi K. A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem Sci 2001;26:465-8
15. McGraw WT, Potempa J, Farley D, et al. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 1999;67:3248-56.
16. Abdullah SN, Farmer EA, Spargo L, et al. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity. Anaerobe 2013;23:102-8
17. Potempa J, Pike R, Travis J. The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun 1995;63: 1176-82
18. Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010;62:2662-72.
19. Konig MF, Paracha AS, Moni M, et al. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology. Ann Rheum Dis 2015;74:2054-61.
20. Andrade F, Darrah E, Gucek M, et al. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum 2010;62:1630-40.
21. Quirke AM, Lundberg K, Potempa J, PPAD remains a credible candidate for inducing autoimmunity in rheumatoid arthritis: comment on the article by Konig et al. Ann Rheum Dis 2015;74:e7.
22. Sarkar G, Sommer SS. The "megaprimer" method of site-directed mutagenesis. Biotechniques 1990;8:404-7.
23. Vossenaar ER, Radstake TR, van der Heijden A, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63:373-81.
24. Rodriguez SB, Stitt BL, Ash DE. Expression of peptidylarginine deiminase from Porphyromonas gingivalis in Escherichia coli: enzyme purification and characterization. Arch Biochem Biophys 2009;488:14-22.
25. Wessel D, Flugge UI. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem 1984;138:141-3.
26. Rodriguez SB, Stitt BL, Ash DE. Cysteine 351 is an essential nucleophile in catalysis by Porphyromonas gingivalis peptidylarginine deiminase. Arch Biochem Biophys 2010;504:190-6.
27. Lu X, Galkin A, Herzberg O, et al. Arginine deiminase uses an active-site cysteine in nucleophilic catalysis of L-arginine hydrolysis. J Am Chem Soc 2004;126:5374-5.
28. Shoji M, Sato K, Yukitake H, et al. Por secretion system-dependent secretion and glycosylation of Porphyromonas gingivalis hemin-binding protein 35. PLoS One 2011;6:e21372.
29. Veith PD, Chen YY, Gorasia DG, et al. Porphyromonas gingivalis outer membrane vesicles exclusively contain outer membrane and periplasmic proteins and carry a cargo enriched with virulence factors. J Proteome Res 2014;13:2420-32.
30. Zhou XY, Gao JL, Hunter N, et al. Sequence-independent processing site of the C-terminal domain (CTD) influences maturation of the RgpB protease from Porphyromonas gingivalis. Mol Microbiol 2013;89:903-17.
31. Wegner N, Lundberg K, Kinloch A, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010;233:34-54.
32. van Beers JJ, Raijmakers R, Alexander LE, et al. Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance. Arthritis Res Ther 2010;12:R219.
33. Hill JA, Southwood S, Sette A, et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1∗0401 MHC class II molecule. J Immunol 2003;171:538-41.
34. James EA, Moustakas AK, Bui J, et al. HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets. Arthritis Rheum 2010;62:2909-18.
35. James EA, Rieck M, Pieper J, et al. Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy. Arthritis Rheumatol 2014;66:1712-22.
36. Wegner N. Protein citrullination by Porphyromonas gingivalis and its implications for autoimmunity in rheumatoid arthritis [.]. Imperial College London, 2011.
37. Ireland JM, Unanue ER. Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4T cells. J Exp Med 2011;208:2625-32.
38. Lappin DF, Apatzidou D, Quirke AM, et al. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol 2013;40:907-15.
39. Brink M, Hansson M, Mathsson L, et al. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum 2013;65:899-910.
40. Montgomery AB, Lugli EB, Venables P. Is Citrullination the Missing Link between Periodontal Disease and Rheumatoid Arthritis? Current Oral Health Reports 2015;2:30-6.